Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6252)
All Articles published online
|
Publishing Process of This Article
|
Oct 10, 2014 (publication date) through Feb 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Leong D, Rai R, Nguyen B, Lee A, Yip D. Advances in adjuvant systemic therapy for non-small-cell lung cancer. World J Clin Oncol 2014; 5(4): 633-645 [PMID: 25302167 DOI: 10.5306/wjco.v5.i4.633] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v5/i4/633.htm |
| Number | Citing Articles |
| 1 |
Masahiko Higashiyama, Makoto Takahama, Akihide Matsumura, Hajime Maeda, Mitsunori Ohta, Meinoshin Okumura, Koichi Yoshikawa, Cheng-long Huang, Hirohito Tada, Ken Kodama. Time Trend in Postoperative Adjuvant Chemotherapy for Stage I-IIIA Non-small Cell Lung Cancer: a Questionnaire Survey of the Osaka Lung Cancer Study Group (OLCSG). Haigan 2015; 55(7): 1055 doi: 10.2482/haigan.55.1055
|
| 2 |
Yuling Bin, Yong Ding, Weisheng Xiao, Aijun Liao. RASSF1A: A promising target for the diagnosis and treatment of cancer. Clinica Chimica Acta 2020; 504: 98 doi: 10.1016/j.cca.2020.01.014
|
| 3 |
Di Zheng, Jie Zhang, Jian Ni, Jie Luo, Jiying Wang, Liang Tang, Ling Zhang, Li Wang, Jianfang Xu, Bo Su, Gang Chen. Small nucleolar RNA 78 promotes the tumorigenesis in non-small cell lung cancer. Journal of Experimental & Clinical Cancer Research 2015; 34(1) doi: 10.1186/s13046-015-0170-5
|
| 4 |
Weiwei Zhang, Hao Feng, Hao Wu, Xiaoqi Zheng. Accounting for tumor purity improves cancer subtype classification from DNA methylation data. Bioinformatics 2017; 33(17): 2651 doi: 10.1093/bioinformatics/btx303
|
| 5 |
Fei Xu, Wenqiang Cui, Zhengxiao Zhao, Weiyi Gong, Ying Wei, Jiaqi Liu, Mihui Li, Qiuping Li, Chen Yan, Jian Qiu, Baojun Liu, Jingcheng Dong, Valeria Sulsen. Targeting Tumor Microenvironment: Effects of Chinese Herbal Formulae on Macrophage‐Mediated Lung Cancer in Mice. Evidence-Based Complementary and Alternative Medicine 2017; 2017(1) doi: 10.1155/2017/7187168
|
| 6 |
Marie-Catherine Morgant, Pierre-Benoit Pagès, Bastien Orsini, Pierre-Emmanuel Falcoz, Pascal-Alexandre Thomas, Françoise Le Pimpec Barthes, Marcel Dahan, Alain Bernard. Time trends in surgery for lung cancer in France from 2005 to 2012: a nationwide study. European Respiratory Journal 2015; 46(4): 1131 doi: 10.1183/13993003.00354-2015
|
| 7 |
|
| 8 |
Yuki Akazawa, Masahiko Higashiyama, Kazumi Nishino, Jyunji Uchida, Toru Kumagai, Takako Inoue, Ayako Fujiwara, Toshiteru Tokunaga, Jiro Okami, Fumio Imamura, Ken Kodama, Hisayuki Kobayashi. Impact of in vitro chemosensitivity test-guided platinum-based adjuvant chemotherapy on the surgical outcomes of patients with p-stage IIIA non-small cell lung cancer that underwent complete resection. Molecular and Clinical Oncology 2017; 7(3): 327 doi: 10.3892/mco.2017.1340
|
| 9 |
Quan Huang, Lei Li, Lin Li, Hui Chen, Yongyan Dang, Jishen Zhang, Naimin Shao, Hong Chang, Zhengjie Zhou, Chongyi Liu, Bingwei He, Haifeng Wei, Jianru Xiao. MDM2 knockdown mediated by a triazine-modified dendrimer in the treatment of non-small cell lung cancer. Oncotarget 2016; 7(28): 44013 doi: 10.18632/oncotarget.9768
|
| 10 |
Jiandong Mei, Zhilan Xiao, Chenglin Guo, Qiang Pu, Lin Ma, Chengwu Liu, Feng Lin, Hu Liao, Zongbing You, Lunxu Liu. Prognostic impact of tumor-associated macrophage infiltration in non-small cell lung cancer: A systemic review and meta-analysis. Oncotarget 2016; 7(23): 34217 doi: 10.18632/oncotarget.9079
|
| 11 |
Chuang Han, Yu Wu. A model of NSCLC microenvironment predicts optimal receptor targets. Quantitative Biology 2019; 7(2): 147 doi: 10.1007/s40484-019-0171-z
|
| 12 |
Nunzio Antonio Cacciola, Romina Sepe, Floriana Forzati, Antonella Federico, Simona Pellecchia, Umberto Malapelle, Alfonso De Stefano, Danilo Rocco, Alfredo Fusco, Pierlorenzo Pallante. Restoration of CBX7 expression increases the susceptibility of human lung carcinoma cells to irinotecan treatment. Naunyn-Schmiedeberg's Archives of Pharmacology 2015; 388(11): 1179 doi: 10.1007/s00210-015-1153-y
|
| 13 |
Jiliang Cheng, Zhaoxiang Fang, Huanhuan Yang, Yong Li, Haishan Tian, Weiyue Gong, Taotao Chen, Min Liu, Xiaokun Li, Chao Jiang. High-yield of biologically active recombinant human fibroblast growth factor-16 inE. coliand its mechanism of proliferation in NCL-H460 cells. Preparative Biochemistry & Biotechnology 2017; 47(7): 720 doi: 10.1080/10826068.2017.1315599
|
| 14 |
Yue Hu, Shan Liu, Lixing Wang, Yu Liu, Duohan Zhang, Yinlong Zhao. Treatment-free survival after discontinuation of immune checkpoint inhibitors in mNSCLC: a systematic review and meta-analysis. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1202822
|
| 15 |
Ming Ming, Feng-Yin Sun, Wen-Tong Zhang, Ji-Ke Liu. Therapeutic effect of oridonin on mice with prostate cancer. Asian Pacific Journal of Tropical Medicine 2016; 9(2): 184 doi: 10.1016/j.apjtm.2016.01.007
|